BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 37212253)

  • 1. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
    Barnes DR; Rookus MA; McGuffog L; Leslie G; Mooij TM; Dennis J; Mavaddat N; Adlard J; Ahmed M; Aittomäki K; Andrieu N; Andrulis IL; Arnold N; Arun BK; Azzollini J; Balmaña J; Barkardottir RB; Barrowdale D; Benitez J; Berthet P; Białkowska K; Blanco AM; Blok MJ; Bonanni B; Boonen SE; Borg Å; Bozsik A; Bradbury AR; Brennan P; Brewer C; Brunet J; Buys SS; Caldés T; Caligo MA; Campbell I; Christensen LL; Chung WK; Claes KBM; Colas C; ; ; Collonge-Rame MA; Cook J; Daly MB; Davidson R; de la Hoya M; de Putter R; Delnatte C; Devilee P; Diez O; Ding YC; Domchek SM; Dorfling CM; Dumont M; Eeles R; Ejlertsen B; Engel C; Evans DG; Faivre L; Foretova L; Fostira F; Friedlander M; Friedman E; Frost D; Ganz PA; Garber J; Gehrig A; Gerdes AM; Gesta P; Giraud S; Glendon G; Godwin AK; Goldgar DE; González-Neira A; Greene MH; Gschwantler-Kaulich D; Hahnen E; Hamann U; Hanson H; Hentschel J; Hogervorst FBL; Hooning MJ; Horvath J; Hu C; Hulick PJ; Imyanitov EN; ; ; ; Isaacs C; Izatt L; Izquierdo A; Jakubowska A; James PA; Janavicius R; John EM; Joseph V; Karlan BY; Kast K; Koudijs M; Kruse TA; Kwong A; Laitman Y; Lasset C; Lazaro C; Lester J; Lesueur F; Liljegren A; Loud JT; Lubiński J; Mai PL; Manoukian S; Mari V; Mebirouk N; Meijers-Heijboer HEJ; Meindl A; Mensenkamp AR; Miller A; Montagna M; Mouret-Fourme E; Mukherjee S; Mulligan AM; Nathanson KL; Neuhausen SL; Nevanlinna H; Niederacher D; Nielsen FC; Nikitina-Zake L; Noguès C; Olah E; Olopade OI; Ong KR; O'Shaughnessy-Kirwan A; Osorio A; Ott CE; Papi L; Park SK; Parsons MT; Pedersen IS; Peissel B; Peixoto A; Peterlongo P; Pfeiler G; Phillips KA; Prajzendanc K; Pujana MA; Radice P; Ramser J; Ramus SJ; Rantala J; Rennert G; Risch HA; Robson M; Rønlund K; Salani R; Schuster H; Senter L; Shah PD; Sharma P; Side LE; Singer CF; Slavin TP; Soucy P; Southey MC; Spurdle AB; Steinemann D; Steinsnyder Z; Stoppa-Lyonnet D; Sutter C; Tan YY; Teixeira MR; Teo SH; Thull DL; Tischkowitz M; Tognazzo S; Toland AE; Trainer AH; Tung N; van Engelen K; van Rensburg EJ; Vega A; Vierstraete J; Wagner G; Walker L; Wang-Gohrke S; Wappenschmidt B; Weitzel JN; Yadav S; Yang X; Yannoukakos D; Zimbalatti D; Offit K; Thomassen M; Couch FJ; Schmutzler RK; Simard J; Easton DF; Chenevix-Trench G; Antoniou AC;
    Genet Med; 2020 Oct; 22(10):1653-1666. PubMed ID: 32665703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers.
    Borde J; Laitman Y; Blümcke B; Niederacher D; Weber-Lassalle K; Sutter C; Rump A; Arnold N; Wang-Gohrke S; Horváth J; Gehrig A; Schmidt G; Dutrannoy V; Ramser J; Hentschel J; Meindl A; Schroeder C; Wappenschmidt B; Engel C; Kuchenbaecker K; Schmutzler RK; Friedman E; Hahnen E; Ernst C
    BMC Cancer; 2022 Jun; 22(1):706. PubMed ID: 35761208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of germline pathogenic
    Morgan RD; Burghel GJ; Flaum N; Bulman M; Clamp AR; Hasan J; Mitchell CL; Schlecht H; Woodward ER; Lallo FI; Crosbie EJ; Edmondson RJ; Wallace AJ; Jayson GC; Evans DGR
    J Med Genet; 2019 May; 56(5):301-307. PubMed ID: 30683677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
    Dareng EO; Tyrer JP; Barnes DR; Jones MR; Yang X; Aben KKH; Adank MA; Agata S; Andrulis IL; Anton-Culver H; Antonenkova NN; Aravantinos G; Arun BK; Augustinsson A; Balmaña J; Bandera EV; Barkardottir RB; Barrowdale D; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bernardini MQ; Bjorge L; Black A; Bogdanova NV; Bonanni B; Borg A; Brenton JD; Budzilowska A; Butzow R; Buys SS; Cai H; Caligo MA; Campbell I; Cannioto R; Cassingham H; Chang-Claude J; Chanock SJ; Chen K; Chiew YE; Chung WK; Claes KBM; Colonna S; ; ; ; Cook LS; Couch FJ; Daly MB; Dao F; Davies E; de la Hoya M; de Putter R; Dennis J; DePersia A; Devilee P; Diez O; Ding YC; Doherty JA; Domchek SM; Dörk T; du Bois A; Dürst M; Eccles DM; Eliassen HA; Engel C; Evans GD; Fasching PA; Flanagan JM; Fortner RT; Machackova E; Friedman E; Ganz PA; Garber J; Gensini F; Giles GG; Glendon G; Godwin AK; Goodman MT; Greene MH; Gronwald J; ; ; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hansen TVO; Harris HR; Hartman M; Heitz F; Hildebrandt MAT; Høgdall E; Høgdall CK; Hopper JL; Huang RY; Huff C; Hulick PJ; Huntsman DG; Imyanitov EN; ; ; Isaacs C; Jakubowska A; James PA; Janavicius R; Jensen A; Johannsson OT; John EM; Jones ME; Kang D; Karlan BY; Karnezis A; Kelemen LE; Khusnutdinova E; Kiemeney LA; Kim BG; Kjaer SK; Komenaka I; Kupryjanczyk J; Kurian AW; Kwong A; Lambrechts D; Larson MC; Lazaro C; Le ND; Leslie G; Lester J; Lesueur F; Levine DA; Li L; Li J; Loud JT; Lu KH; Lubiński J; Mai PL; Manoukian S; Marks JR; Matsuno RK; Matsuo K; May T; McGuffog L; McLaughlin JR; McNeish IA; Mebirouk N; Menon U; Miller A; Milne RL; Minlikeeva A; Modugno F; Montagna M; Moysich KB; Munro E; Nathanson KL; Neuhausen SL; Nevanlinna H; Yie JNY; Nielsen HR; Nielsen FC; Nikitina-Zake L; Odunsi K; Offit K; Olah E; Olbrecht S; Olopade OI; Olson SH; Olsson H; Osorio A; Papi L; Park SK; Parsons MT; Pathak H; Pedersen IS; Peixoto A; Pejovic T; Perez-Segura P; Permuth JB; Peshkin B; Peterlongo P; Piskorz A; Prokofyeva D; Radice P; Rantala J; Riggan MJ; Risch HA; Rodriguez-Antona C; Ross E; Rossing MA; Runnebaum I; Sandler DP; Santamariña M; Soucy P; Schmutzler RK; Setiawan VW; Shan K; Sieh W; Simard J; Singer CF; Sokolenko AP; Song H; Southey MC; Steed H; Stoppa-Lyonnet D; Sutphen R; Swerdlow AJ; Tan YY; Teixeira MR; Teo SH; Terry KL; Terry MB; ; ; Thomassen M; Thompson PJ; Thomsen LCV; Thull DL; Tischkowitz M; Titus L; Toland AE; Torres D; Trabert B; Travis R; Tung N; Tworoger SS; Valen E; van Altena AM; van der Hout AH; Van Nieuwenhuysen E; van Rensburg EJ; Vega A; Edwards DV; Vierkant RA; Wang F; Wappenschmidt B; Webb PM; Weinberg CR; Weitzel JN; Wentzensen N; White E; Whittemore AS; Winham SJ; Wolk A; Woo YL; Wu AH; Yan L; Yannoukakos D; Zavaglia KM; Zheng W; Ziogas A; Zorn KK; Kleibl Z; Easton D; Lawrenson K; DeFazio A; Sellers TA; Ramus SJ; Pearce CL; Monteiro AN; Cunningham J; Goode EL; Schildkraut JM; Berchuck A; Chenevix-Trench G; Gayther SA; Antoniou AC; Pharoah PDP
    Eur J Hum Genet; 2022 Mar; 30(3):349-362. PubMed ID: 35027648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of polygenic risk scores in BRCA1/2 pathogenic variant heterozygotes in epithelial ovarian cancer.
    Flaum N; Bowes J; Smith MJ; Crosbie EJ; Edmondson R; Lophatananon A; Evans DG
    Genet Med; 2023 Sep; 25(9):100898. PubMed ID: 37212253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial ovarian cancer risk: A review of the current genetic landscape.
    Flaum N; Crosbie EJ; Edmondson RJ; Smith MJ; Evans DG
    Clin Genet; 2020 Jan; 97(1):54-63. PubMed ID: 31099061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.
    Arts-de Jong M; de Bock GH; van Asperen CJ; Mourits MJ; de Hullu JA; Kets CM
    Eur J Cancer; 2016 Jul; 61():137-45. PubMed ID: 27209246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Genetic Characteristics of BRCA1/2 Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review.
    Kwon BS; Byun JM; Lee HJ; Jeong DH; Lee TH; Shin KH; Suh DS; Kim KH
    Cancer Res Treat; 2019 Jul; 51(3):941-950. PubMed ID: 30309222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis.
    Sun C; Li N; Ding D; Weng D; Meng L; Chen G; Ma D
    PLoS One; 2014; 9(5):e95285. PubMed ID: 24788697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
    Weischer M; Bojesen SE; Ellervik C; Tybjaerg-Hansen A; Nordestgaard BG
    J Clin Oncol; 2008 Feb; 26(4):542-8. PubMed ID: 18172190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.
    Machackova E; Claes K; Mikova M; Házová J; Sťahlová EH; Vasickova P; Trbusek M; Navrátilová M; Svoboda M; Foretová L
    Klin Onkol; 2019; 32(Supplementum2):51-71. PubMed ID: 31409081
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.